DP
Therapeutic Areas
Pharma Mar Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Yondelis (trabectedin) | Soft Tissue Sarcoma, Ovarian Cancer | Approved |
| Zepzelca (lurbinectedin) | Small Cell Lung Cancer (2nd Line) | Approved |
| PM54 (ecubectedin) | Solid Tumors | Phase 1 |
| Aplidin (plitidepsin) | Multiple Myeloma | Approved (Conditional) |
| PM14 | Solid Tumors | Preclinical |